Saby George
Papers
3
Total Citations
118
H-Index
3
About
Dr. Saby George is a leading oncologist and researcher whose work focuses on improving outcomes for patients with bladder cancer, particularly through the optimization of neoadjuvant chemotherapy and surgical strategies. His major contributions center on understanding the factors that influence complete pathologic response (pT0) to chemotherapy before cystectomy—a key predictor of long-term survival. In a highly cited 2015 study (61 citations), Dr. George identified clinical predictors of achieving pT0, offering critical guidance for treatment planning. He has also shed light on the underappreciated issues of chemotherapy avoidance, refusal, and abandonment before and after cystectomy (2013, 34 citations), highlighting barriers to optimal care. Furthermore, his multinational, multicenter investigation into suboptimal neoadjuvant chemotherapy dosing (2016, 23 citations) demonstrated its negative impact on peri-operative outcomes and survival following robot-assisted radical cystectomy. Through these impactful studies, Dr. George has advanced personalized treatment approaches and underscored the importance of adherence to evidence-based protocols, making him a respected voice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3